EmAlexNet: Deep Multi-Scale Modified AlexNet Ensemble With Gated Residual Fusion and Dual Attention for Acute Lymphoblastic Leukemia Classification
The utility of combining matched architectures trained with different objective formulations and random initializations under the evaluated repository-level protocol is supported, but external patient-grouped and multicenter validation is required before the clinical utility of EmAlexNet can be assessed.